BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 11, 2020
View Archived Issues
Bayer begins phase II study of inhaled PEGylated adrenomedullin in ARDS
Read More
Statins present antifungal and antibiofilm potential against S. schenckii complex species in vitro
Read More
Localized bile acid improves systemic blood glucose control
Read More
"The joints are elsewhere": for neurodegeneration, a different way to slice the pie
Read More
Araim Pharmaceuticals reports phase II data for cibinetide in DME
Read More
Discovery of SHS-4121705 as a novel mitochondrial uncoupler for the treatment of NASH
Read More
FDA clears IND to expand phase II study of favipiravir for the prevention of COVID-19
Read More
Positive topline data from phase Ib study of AG-019
Read More
Nuvation Bio identifies new adenosine A2A receptor antagonists
Read More
New protein kinase inhibitors discovered at Voronoi
Read More
First patient dosed in clinical trial of Allocetra in severe COVID-19
Read More
Abbisko Therapeutics discloses Nuclear receptor RORgammaT agonists
Read More
New RIP-1 kinase 1 inhibitors synthesized at Beijing Scitech-Mq Pharmaceuticals
Read More
HitGen patents STING agonists
Read More
AnaptysBio reports interim analysis data from ECLIPSE phase II study of etokimab
Read More
FDA gives may proceed notice for phase IIb/III study of SLS-005 in ALS
Read More
IDMC recommends continuation of phase IIb trial of XF-73 for postsurgical bacterial infections
Read More
Positive interim data presented from EQUATE study of itolizumab in acute GvHD
Read More
Phase III data show ensartinib significantly prolongs PFS over crizotinib in ALK-positive NSCLC
Read More
Phase IIa study of KY-1005 in atopic dermatitis meets primary endpoints
Read More
New triple-modal nanoparticle therapy overcomes drug resistance in bladder cancer models
Read More